To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

Open menu Search

Lockheed Martin to enhance exoskeleton tech

13th April 2017 - 12:30 GMT | by The Shephard News Team


Lockheed Martin has licensed B-Temia's bionic augmentation technology, Dermoskeleton, as it looks to enhance its exoskeleton solutions.

Dermoskeleton is the basis for computer-controlled devices that can increase mobility and load-carrying capacity by counteracting overstress on the lower back and legs. The technology offers a potential pathway to increase loadbearing and agility in Lockheed Martin's FORTIS industrial exoskeleton.

Lockheed Martin's technology license permits use of B-Temia technology to products for military, industrial, commercial and first-responder applications.

The FORTIS exoskeleton is an unpowered, lightweight exoskeleton that increases an operator's strength and endurance by transferring the weight of heavy loads from the operator's body directly to the ground through a series of joints at the hips, knees and ankles.

B-Temia's Dermoskeleton technology provides improved mobility, strength and autonomy to the user, with applications in the medical, industrial and military fields.

The Shephard News Team


The Shephard News Team

As part of our promise to deliver comprehensive coverage to Premium News and Defence Insight …

Read full bio

Share to